Richard B. Moss

Professor of Pediatrics at the Lucile Salter Packard Children's Hospital, Emeritus
Richard B. Moss, MD, is former chief of the Pediatric Pulmonary and Allergy Divisions, and allergy-immunology and pulmonary fellowship training programs director, at Stanford University. He was educated at Columbia (BA), SUNY Downstate (MD), Northwestern/Children’s Memorial Hospital (pediatrics residency) and Stanford (allergy-immunology, pulmonology fellowships). He was Director of the Cystic Fibrosis Center at Stanford (1991-2009) and site principal investigator for the Cystic Fibrosis Therapeutics Development Network (1999-2009), where he was also inaugural Chair of the Protocol Review Committee. He currently is a member of Stanford’s Child Health Research Institute, serves on the Pediatric Mentoring Program at Stanford, the Executive Committee of Stanford’s NIH clinical research program (Spectrum Child Health) and the Stanford IRB. Dr. Moss has reviewed and consulted for the NIH, CFF, national and international foundations, peer-review journals and biopharmaceutical companies. His research interests include immunopathogenesis, outcome measures, and treatment of chronic airway diseases of childhood. Recent work has focused on allergic fungal lung disease.

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (1981)

Residency: Northwestern University Feinberg School of Medicine (1977) IL

Fellowship: Stanford University School of Medicine (1981) CA

Medical Education: SUNY Downstate College of Medicine (1975) NY

Board Certification: Diagnostic Laboratory Immunology, American Board of Allergy and Immunology (1986)

Board Certification: Allergy and Immunology, American Board of Allergy and Immunology (1981)

Internship: Children's Memorial Hospital (1976) IL

BA, Columbia University, Political Science (1971)

MD, SUNY Downstate Med Center NYC, Medicine (1975)

Honors & Awards

Top Doctors as Chosen by Their Peers - Pediatric Pulmology, US News and World Report (2012/2013)

Top Doctors - Pediatric Pulmonology Ten Years Award, Castle Connolly Medical Ltd American Registry (2002-2012)

Professional of the Year, Cystic Fibrosis Foundation, N. Cal chapter (2008)

Best Doctors in America, Best Doctors (2001-)

America's Top Pediatricians-Pulmonology, Consumers Research Council of America (2002-)

Professional of the Year, Cystic Fibrosis Research, Inc. (2003)

Member, American Pediatric Society (2005)

Who's Who in America, Marquis (2006)

Administrative Appointments

Member, Stanford IRB (2010 - Present)

Executive Committee, SPECTRUM Child Health (2009 - Present)

Director, Allergy-Immunology Fellowship Training Program, Stanford University (2006 - 2011)

Chief, Allergy-Immunology, Pediatrics, Stanford University (2005 - 2009)

Director, Cystic Fibrosis Center, Stanford University (1991 - 2009)

Principal Investigator, CF Therapeutics Development Network Center, Stanford University (1999 - 2009)

Chief, Pediatric Pulmonology, Stanford University (1991 - 2006)

Co-Director, Allergy-Immunology Felllowship Training Program, Stanford University (1989 - 1995)

Chair, Protocol Review Committee, Cystic Fibrosis Therapeutic Development Network, Cystic Fibrosis Foundation (2002 - 2005)

Chief, Allergy-Immunology, Pediatrics, Stanford University (1991 - 1996)

A Little CFTR Goes a Long Way: CFTR-Dependent Sweat Secretion from G551D and R117H-5T Cystic Fibrosis Subjects Taking Ivacaftor
Char, J. E., Wolfe, M. H., Cho, H.- ju, Park, I.-H., Jeong, J. H., & Wine, J. J. (2014). A Little CFTR Goes a Long Way: CFTR-Dependent Sweat Secretion from G551D and R117H-5T Cystic Fibrosis Subjects Taking Ivacaftor. PLos One.

Sleep-disordered breathing in children with spinal muscular atrophy Type II and III
Yuan N, Moss R, & Wang C. Sleep-disordered breathing in children with spinal muscular atrophy Type II and III. submitted.

Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation
Rowe, S. M., Liu, B., Hill, A., Hathorne, H., Cohen, M., & Clancy, J. P. (2013). Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation. PLOS ONE, 8(7).

Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis
Moss, R. B., Mistry, S. J., Konstan, M. W., Pilewski, J. M., Kerem, E., & Lazaar, A. L. (2013). Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis. JOURNAL OF CYSTIC FIBROSIS, 12(3), 241-248.

Sputum Tobramycin Concentrations in Cystic Fibrosis Patients with Repeated Administration of Inhaled Tobramycin
Ruddy, J., Emerson, J., Moss, R., Genatossio, A., McNamara, S., & Rosenfeld, M. (2013). Sputum Tobramycin Concentrations in Cystic Fibrosis Patients with Repeated Administration of Inhaled Tobramycin. JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 26(2), 69-75.

Pitfalls of Drug Development: Lessons Learned from Trials of Denufosol in Cystic Fibrosis
Moss, R. B. (2013). Pitfalls of Drug Development: Lessons Learned from Trials of Denufosol in Cystic Fibrosis. JOURNAL OF PEDIATRICS, 162(4), 676-680.

Treatment Options in Severe Fungal Asthma and Allergic Bronchopulmonary Aspergillosis
Moss, R. (2013). Treatment Options in Severe Fungal Asthma and Allergic Bronchopulmonary Aspergillosis. Eur Respir J.

Current Treatment Options for Invasive Aspergillosis
Batista MV, Costa SF, Shikanai-Yasuda MA, & Moss RB. (2013). Current Treatment Options for Invasive Aspergillosis. Drugs of Today, 49(3).

Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis J, & Denning D. (2013). Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy, 43.

Long term effects of denufosol tetrasodium in patients with cystic fibrosis
Ratjen, F., Durham, T., Navratil, T., Schaberg, A., Accurso, F. J., & Moss, R. B. (2012). Long term effects of denufosol tetrasodium in patients with cystic fibrosis. JOURNAL OF CYSTIC FIBROSIS, 11(6), 539-549.

Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens
Gernez, Y., Dunn, C. E., Everson, C., Mitsunaga, E., Gudiputi, L., & Moss, R. B. (2012). Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens. JOURNAL OF CYSTIC FIBROSIS, 11(6), 502-510.

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
Clancy, J. P., Rowe, S. M., Accurso, F. J., Aitken, M. L., Amin, R. S., & Konstan, M. W. (2012). Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. THORAX, 67(1), 12-18.

Results of a Phase 2a study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis and homozygous for the F508del-CFTR mutation
Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, & Konstan MW. (2012). Results of a Phase 2a study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis and homozygous for the F508del-CFTR mutation. Thorax, 67(1).

Fungi and allergic lower respiratory tract diseases
Knutsen AP, Bush RK, Demain JG, Denning DW, Dixit A, & Wardlaw AJ. (2012). Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol, 129.

The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis
Moss, R. B. (2012). The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis. ADVANCES AGAINST ASPERGILLOSIS I, 1272, 49-57.

A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., & Elborn, J. S. (2011). A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation. NEW ENGLAND JOURNAL OF MEDICINE, 365(18), 1663-1672.

Socioeconomic Status and the Likelihood of Antibiotic Treatment for Signs and Symptoms of Pulmonary Exacerbation in Children with Cystic Fibrosis
Schechter, M. S., McColley, S. A., Regelmann, W., Millar, S. J., Pasta, D. J., & Morgan, W. J. (2011). Socioeconomic Status and the Likelihood of Antibiotic Treatment for Signs and Symptoms of Pulmonary Exacerbation in Children with Cystic Fibrosis. JOURNAL OF PEDIATRICS, 159(5), 819-U158.

Comparative Efficacy and Safety of 4 Randomized Regimens to Treat Early Pseudomonas aeruginosa Infection in Children With Cystic Fibrosis
Treggiari, M. M., Retsch-Bogart, G., Mayer-Hamblett, N., Khan, U., Kulich, M., & Ramsey, B. W. (2011). Comparative Efficacy and Safety of 4 Randomized Regimens to Treat Early Pseudomonas aeruginosa Infection in Children With Cystic Fibrosis. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 165(9), 847-856.

Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function
Accurso, F. J., Moss, R. B., Wilmott, R. W., Anbar, R. D., Schaberg, A. E., & Ramsey, B. W. (2011). Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 183(5), 627-634.

Denufosol Tetrasodium by Inhalation in Patients with Cystic Fibrosis and Mild Pulmonary Function Impairment
Accurso FJ, Moss RB, Wilmott RW, Anbar RD, Schaberg AE, & TIGER-1 Investigator Study Group. (2011). Denufosol Tetrasodium by Inhalation in Patients with Cystic Fibrosis and Mild Pulmonary Function Impairment. Am J Resp Crit Care Med, 183.

Lessons learned from the denufosol trials
Moss RB. (2011). Lessons learned from the denufosol trials. Pediatric Pulmonology, Suppl 34.

METABOLITE PROFILING OF CF AIRWAY FLUID SUGGESTS A ROLE FOR CATECHOLAMINES IN EARLY AND CHRONIC DISEASE
Gudiputi, L., Aronov, P., Makam, M., Zirbes, J., Conrad, C., & Tirouvanziam, R. (2011). METABOLITE PROFILING OF CF AIRWAY FLUID SUGGESTS A ROLE FOR CATECHOLAMINES IN EARLY AND CHRONIC DISEASE. PEDIATRIC PULMONOLOGY, 240-240.

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation
Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M. P., Dunitz, J. M., & Ramsey, B. W. (2010). Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation. NEW ENGLAND JOURNAL OF MEDICINE, 363(21), 1991-2003.

Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis
Moss, R. B. (2010). Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis. CURRENT OPINION IN PULMONARY MEDICINE, 16(6), 598-603.

Baseline Characteristics and Factors Associated With Nutritional and Pulmonary Status at Enrollment in the Cystic Fibrosis EPIC Observational Cohort
Rosenfeld, M., Emerson, J., McNamara, S., Joubran, K., Retsch-Bogart, G., & Gibson, R. L. (2010). Baseline Characteristics and Factors Associated With Nutritional and Pulmonary Status at Enrollment in the Cystic Fibrosis EPIC Observational Cohort. PEDIATRIC PULMONOLOGY, 45(9), 934-944.

Safety, Tolerability, and Efficacy of High-Frequency Chest Wall Oscillation in Pediatric Patients With Cerebral Palsy and Neuromuscular Diseases: An Exploratory Randomized Controlled Trial
Yuan, N., Kane, P., Shelton, K., Matel, J., Becker, B. C., & Moss, R. B. (2010). Safety, Tolerability, and Efficacy of High-Frequency Chest Wall Oscillation in Pediatric Patients With Cerebral Palsy and Neuromuscular Diseases: An Exploratory Randomized Controlled Trial. JOURNAL OF CHILD NEUROLOGY, 25(7), 815-821.

SURVEY TO ASSESS RESEARCH SATISFACTION AT STANFORD (STARS)
DAVIES, Z., Dunn, C. E., Hernandez, C., Zirbes, J. M., Milla, C., & Moss, R. B. (2010). SURVEY TO ASSESS RESEARCH SATISFACTION AT STANFORD (STARS). PEDIATRIC PULMONOLOGY, 401-401.

Allergic bronchopulmonary aspergillosis
Moss RB. (2010). Allergic bronchopulmonary aspergillosis. eCysticFibrosis Review (http://www.hopkinscme.net/ofp/eCysticFibrosisReview/index.html).

Cystic Fibrosis Pathophysiology and Therapeutic Targets.
Moss RB. (2010). Cystic Fibrosis Pathophysiology and Therapeutic Targets. Johns Hopkins Advanced Studies in Medicine..

SMALL METABOLITE PROFILING OF AIRWAY FLUID UNCOVERS SPECIFIC ALTERATIONS IN CF
Tirouvanziam, R., Aronov, P., Laval, J., Makam, M., Liu, C., & Moss, R. B. (2010). SMALL METABOLITE PROFILING OF AIRWAY FLUID UNCOVERS SPECIFIC ALTERATIONS IN CF. PEDIATRIC PULMONOLOGY, 243-243.

Cystic Fibrosis HRCT Scores Correlate Strongly With Pseudomonas Infection
Robinson, T. E., Leung, A. N., Chen, X., Moss, R. B., & Emond, M. J. (2009). Cystic Fibrosis HRCT Scores Correlate Strongly With Pseudomonas Infection. PEDIATRIC PULMONOLOGY, 44(11), 1107-1117.

Genetic Modifiers of Liver Disease in Cystic Fibrosis
Bartlett, J. R., Friedman, K. J., Ling, S. C., Pace, R. G., Bell, S. C., & Knowles, M. R. (2009). Genetic Modifiers of Liver Disease in Cystic Fibrosis. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 302(10), 1076-1083.

Infection, inflammation and the downward spiral of cystic fibrosis lung disease
Moss RB. (2009). Infection, inflammation and the downward spiral of cystic fibrosis lung disease. Journal of Pediatrics, 154.

Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs.
Makam M, Diaz D, Laval J, Gernez Y, Conrad CK, & Tirouvanziam R. (2009). Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc Natl Acad Sci U S A, 106.

Highlights of a workshop to discuss targeting inflammation in cystic fibrosis
Banner K, De Jonge H, Elborn S, Growcott E, Gulbins E, & Thomas. (2009). Highlights of a workshop to discuss targeting inflammation in cystic fibrosis. J Cystic Fibrosis, 8(1).

Allergic bronchopulmonary aspergillosis
Moss RB. (2009). Allergic bronchopulmonary aspergillosis. In Latge JP, Steinbach WJ, Eds. Aspergillus Fumigatus and Aspergillosis. American Society of Microbiology Press.

Profound functional and signalling changes in viable neutrophils homing to cystic fibrosis airways
Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, & Herzenberg LA. (2008). Profound functional and signalling changes in viable neutrophils homing to cystic fibrosis airways. Proceed Natl Acad Sci USA, 105.

The role of fungi in chronic airways infection
Moss RB. (2008). The role of fungi in chronic airways infection. Commentaries on Chronic Airway Infection, 2(14).

Management of allergic aspergillosis
Moss RB. (2008). Management of allergic aspergillosis. Current Fungal Infection Reports.

Chest imaging in cystic fibrosis
Robinson TE, & Moss RB. (2008). Chest imaging in cystic fibrosis. Commentaries on Chronic Airway Infection, 2(3).

Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis
Gibson, R. L., Emerson, J., Mayer-Hamblett, N., Burns, J. L., McNamara, S., & Grp, T. I. Y. C. S. (2007). Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. PEDIATRIC PULMONOLOGY, 42(7), 610-623.

No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations
Clancy, J. P., Rowe, S. M., Bebok, Z., Aitken, M. L., Gibson, R., & Ramsey, B. (2007). No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 37(1), 57-66.

No detectable improvements in CFTR by nasal aminoglycosides in CF patients heterozygous for stop mutations.
Clancy JP, Rowe SM, Bebok Z, Aitken ML, Gibson RL, & Mayer-Ham. (2007). No detectable improvements in CFTR by nasal aminoglycosides in CF patients heterozygous for stop mutations. Am J Resp Molec Cell Biol, 37.

Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo controlled trial.
Moss RB, Milla C, Colombo J, Accurso F, Zeitlin PL, & Pilewski J. (2007). Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo controlled trial. Human Gen Ther, 18.

Aggressive treatment strategies in the fight against cystic fibrosis
Mogayzel PJ, C. Jp. M. Rb. (2007). Aggressive treatment strategies in the fight against cystic fibrosis. Johns Hopkins Advanced Studies in Medicine, 7(14).

Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis.
Gibson RL, Emerson J, Hamblett N, Burns JL, McNamara S, & W. (2007). Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatric Pulmonology, 42.

Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients
Borowitz, D., Goss, C. H., Stevens, C., Hayes, D., Newman, L., & Murray, F. T. (2006). Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients. PANCREAS, 32(3), 258-263.

High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis
Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., & Herzenberg, L. A. (2006). High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 103(12), 4628-4633.

Gene therapy for cystic fibrosis: the rise and fall of a viral vector
Moss RB. (2006). Gene therapy for cystic fibrosis: the rise and fall of a viral vector. US Respiratory Disease.

Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA.
Kurup VP, Knutsen AP, Moss RB, & Bansal N. (2006). Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clin Molec Allergy, 4(1).

Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA.
Kurup, V. P., Knutsen, A. P., Moss, R. B., & Bansal, N. K. (2006). Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clinical and molecular allergy : CMA, 4, 11-?.

The urokinase type plasminogen activator system in induced sputum of patients with asthma
Wang L, Xiao W, Moss RB, & Hsu YP. (2006). The urokinase type plasminogen activator system in induced sputum of patients with asthma. Chinese J TB Resp Dis, 29.

Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease - A quantitative analysis
Robinson, T. E., Goris, M. L., Zhu, H. J., Chen, X. R., Bhise, F., & Moss, R. B. (2005). Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease - A quantitative analysis. CHEST, 128(4), 2327-2335.

Pathophysiology and immunology of allergic bronchopulmonary aspergillosis
Moss, R. B. (2005). Pathophysiology and immunology of allergic bronchopulmonary aspergillosis. MEDICAL MYCOLOGY, 43, S203-S206.

Fungal allergy in cystic fibrosis
Moss RB. (2005). Fungal allergy in cystic fibrosis. Kurup VS, Ed. Mold Allergy, Biology and Pathogenesis. Research Signpost., 37/661(2).

Aspergillus antigens and immunodiagnosis of allergic bronchopulmonary aspergillosis.
Kurup VP, Knutsen AP, & Moss RB. (2005). Aspergillus antigens and immunodiagnosis of allergic bronchopulmonary aspergillosis. In Kurup VS, Ed. Mold Allergy, Biology and Pathogenesis. Research Signpost., 37/661(2).

Fully automated system for three-dimensional bronchial morphology analysis using volumetric multidetector computed tomography of the chest
Venkatraman R, Raman R, Raman B, Moss RB, Rubin GD, & Robinson TE. (2005). Fully automated system for three-dimensional bronchial morphology analysis using volumetric multidetector computed tomography of the chest. J Digital Imaging.

Novel contributions to the Asian CFTR mutation spectrum: genotype and phenotype in Thai patients with cystic fibrosis.
Schrijver I, Karnsakul W, Ramalingam S, Sankaran R, Moss R, & Gardner P. (2005). Novel contributions to the Asian CFTR mutation spectrum: genotype and phenotype in Thai patients with cystic fibrosis. Am J Med Genet, 133.

Diagnostic testing by comprehensive mutation analysis in a large group of Hispanics: novel mutations and assessment of a population-specific mutation spectrum
Schrijver I, Ramalingam S, Sankaran R, Swanson S, Dunlop CLM, & Kammesheidt. (2005). Diagnostic testing by comprehensive mutation analysis in a large group of Hispanics: novel mutations and assessment of a population-specific mutation spectrum. J Molec Diagnostics, 7(2).

Sputum cathelicidin, plasmin activation system components and cytokine patterns discriminate cystic fibrosis, chronic obstructive pulmonary disease and asthma from each other and healthy subjects
Xiao W, Hsu YP, Ishizaka A, Kirikae, & Moss RB. (2005). Sputum cathelicidin, plasmin activation system components and cytokine patterns discriminate cystic fibrosis, chronic obstructive pulmonary disease and asthma from each other and healthy subjects. Chest, 28.

Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.
Moss RB., Mayer-Hamblett N, Wagener J, Daines C, Hale K, & Starko K. (2005). Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease. Pediatr Pulmonol, 39(3).

Quantitative air-trapping analysis in children with mild cystic fibrosis lung disease
Bonnel, A. S., Song, S. Mh., Kesavarju, K., Newaskar, M., Paxton, C. J., & Robinson, T. E. (2004). Quantitative air-trapping analysis in children with mild cystic fibrosis lung disease. PEDIATRIC PULMONOLOGY, 38(5), 396-405.

Lymphocytes in cystic fibrosis lung disease: a tale of two immunities
Moss, R. B. (2004). Lymphocytes in cystic fibrosis lung disease: a tale of two immunities. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 135(3), 358-360.

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis - A multicenter, double-blind, placebo-controlled trial
Moss, R. B., Rochman, D., Spencer, L. T., Aitken, M. L., Zeitlhi, P. L., & Heald, A. E. (2004). Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis - A multicenter, double-blind, placebo-controlled trial. CHEST, 125(2), 509-521.

Cystic Fibrosis: Treatment Practice Guidelines Pocket Guide. Professional Resources in Management Education, Inc
Bloch EA, Germana J, Konstan M, Kuhn R, Llewellyn A, & Wagener J. (2004). Cystic Fibrosis: Treatment Practice Guidelines Pocket Guide. Professional Resources in Management Education, Inc.

Inhalational antibiotics for airways infection
Moss RB. (2004). Inhalational antibiotics for airways infection. Experimental Lung Research, 30(Suppl 1).

Allergic bronchopulmonary aspergillosis with normal serum IgE in a child with cystic fibrosis
Dorsaneo D, Borowitz D, Sharp J, & Moss R. (2004). Allergic bronchopulmonary aspergillosis with normal serum IgE in a child with cystic fibrosis. Ped Asthma Allergy Immunol, 17.

Allergic bronchopulmonary aspergillosis in cystic fibrosis - State of the art: Cystic Fibrosis Foundation Consensus Conference
Stevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., & Mastella, G. (2003). Allergic bronchopulmonary aspergillosis in cystic fibrosis - State of the art: Cystic Fibrosis Foundation Consensus Conference. CLINICAL INFECTIOUS DISEASES, 37, S225-S264.

Advances against aspergillosis
Steinbach, W. J., Stevens, D. A., Denning, D. W., & Moss, R. B. (2003). Advances against aspergillosis. CLINICAL INFECTIOUS DISEASES, 37, S155-S156.

Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease
Robinson, T. E., Leung, A. N., Northway, W. H., Blankenberg, F. G., Chan, F. P., & Moss, R. B. (2003). Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 168(5), 588-593.

Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis
Gibson, R. L., Emerson, J., McNamara, S., Burns, L. L., Rosenfeld, M., & Ramsey, B. (2003). Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 167(6), 841-849.

AAV-CFTR gene therapy for cystic fibrosis: retrospect and prospect
Carter BJ, Munson K, Burstein H, Peluso R, Gerard C, & Moss R. (2003). AAV-CFTR gene therapy for cystic fibrosis: retrospect and prospect. Pediatr Pulmonol, Suppl 25.

Cystic Fibrosis Foundation Consensus Conference recommendations on diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis: executive summary
Moss RB, & Stevens DA. (2003). Cystic Fibrosis Foundation Consensus Conference recommendations on diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis: executive summary. CFF Consensus Conferences, X Sect 3.

AAV-CFTR gene therapy for cystic fibrosis: retrospect and prospect.
Carter BJ, Munson K, Burstein H, Peluso R, Gerard C, & Moss R. (2003). AAV-CFTR gene therapy for cystic fibrosis: retrospect and prospect. Pediatric Pulmonology, Suppl 25.

Allergic bronchopulmonary aspergillosis
Moss, R. B. (2002). Allergic bronchopulmonary aspergillosis. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 23(1), 87-104.

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies
Wagner, J. A., Nepomuceno, I. B., Messner, A. H., Moran, M. L., Batson, E. P., & Gardner, P. (2002). A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. HUMAN GENE THERAPY, 13(11), 1349-1359.

Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis
Moss, R. B. (2002). Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. CHEST, 121(1), 55-63.

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease
Aitken, M. L., Moss, R. B., Waltz, D. A., Dovey, M. E., Tonelli, M. R., & Reynolds, T. C. (2001). A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. HUMAN GENE THERAPY, 12(15), 1907-1916.

Administration of aerosolized antibiotics in cystic fibrosis patients
Moss, R. B. (2001). Administration of aerosolized antibiotics in cystic fibrosis patients. CHEST, 120(3), 107S-113S.

Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis
Robinson, T. E., Leung, A. N., Northway, W. H., Blankenberg, F. G., Bloch, D. A., & Moss, R. B. (2001). Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis. JOURNAL OF PEDIATRICS, 138(4), 553-559.

Comprehensive mutation screening in a cystic fibrosis center
Wine, J. J., Kuo, E., Hurlock, G., & Moss, R. B. (2001). Comprehensive mutation screening in a cystic fibrosis center. PEDIATRICS, 107(2), 280-286.

New approaches to cystic fibrosis
Moss, R. B. (2001). New approaches to cystic fibrosis. HOSPITAL PRACTICE, 36(1), 25-?.

Cystic fibrosis: new insights and treatments
Moss RB. (2001). Cystic fibrosis: new insights and treatments. Hospital Practice, online at http://www.hosppract.com/issues/2001/01/moss.htm.

Cystic fibrosis: new insights and treatments
Moss RB. (2001). Cystic fibrosis: new insights and treatments. Hospital Practice, 36.

Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes
Moss, R. B., Hsu, Y. P., & Olds, L. (2000). Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 120(3), 518-525.

Pulmonary sequelae of bronchopulmonary dysplasia survivors: High-resolution CT findings
Howling, S. J., Northway, W. H., Hansell, D. M., Moss, R. B., Ward, S., & Muller, N. L. (2000). Pulmonary sequelae of bronchopulmonary dysplasia survivors: High-resolution CT findings. AMERICAN JOURNAL OF ROENTGENOLOGY, 174(5), 1323-1326.

Novel Cystic Fibrosis mutation L1093P: functional analysis and possible Native American origin.
Yee, K., Robinson, C., Hurlock, G., Moss, R. B., & Wine, J. J. (2000). Novel Cystic Fibrosis mutation L1093P: functional analysis and possible Native American origin. Human mutation, 15(2), 208-?.

Anti-arthropod saliva antibodies among residents of a community at high risk for Lyme disease in California
Lane, R. S., Moss, R. B., Hsu, Y. P., Wei, T., Mesirow, M. L., & Kuo, M. M. (1999). Anti-arthropod saliva antibodies among residents of a community at high risk for Lyme disease in California. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 61(5), 850-859.

Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein
Illek, B., Zhang, L., Lewis, N. C., Moss, R. B., Dong, J. Y., & Fischer, H. (1999). Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 277(4), C833-C839.

Standardized high-resolution CT of the lung using a spirometer-triggered electron beam CT scanner
Robinson, T. E., Leung, A. N., Moss, R. B., Blankenberg, F. G., Al-Dabbagh, H., & Northway, W. H. (1999). Standardized high-resolution CT of the lung using a spirometer-triggered electron beam CT scanner. AMERICAN JOURNAL OF ROENTGENOLOGY, 172(6), 1636-1638.

Two novel mutations in a cystic fibrosis patient of Chinese origin
Wagner, J. A., Vassilakis, A., Yee, K., Li, M., Hurlock, G., & Wine, J. J. (1999). Two novel mutations in a cystic fibrosis patient of Chinese origin. HUMAN GENETICS, 104(6), 511-515.

Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis
Smith, A. L., Doershuk, C., Goldmann, D., Gore, E., Hilman, B., & YOGEV, R. (1999). Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis. JOURNAL OF PEDIATRICS, 134(4), 413-421.

Allergic bronchopulmonary aspergillosis in cystic fibrosis - Role of atopy and response to itraconazole
Nepomuceno, I. B., Esrig, S., & Moss, R. B. (1999). Allergic bronchopulmonary aspergillosis in cystic fibrosis - Role of atopy and response to itraconazole. CHEST, 115(2), 364-370.

Safety and biological efficacy of an adeno-associated virus vector cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus
Wagner, J. A., Messner, A. H., Moran, M. L., DAIFUKU, R., Kouyama, K., & Gardner, P. (1999). Safety and biological efficacy of an adeno-associated virus vector cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. LARYNGOSCOPE, 109(2), 266-274.

Maxillary sinusitis as a surrogate model for CF gene therapy clinical trials in patients with antrostomies
Wagner, J. A., Nepomuceno, I. B., Shah, N., Messner, A. H., Moran, M. L., & Gardner, P. (1999). Maxillary sinusitis as a surrogate model for CF gene therapy clinical trials in patients with antrostomies. JOURNAL OF GENE MEDICINE, 1(1), 13-21.

Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus
Wagner JA, Moran ML, Messner AH, Diafuku R, Kouyama D, & Gardner. (1999). Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. Laryngoscope, 109.

Chronic intermittment administration of inhaled tobramycin in patients with cystic fibrosis
Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, & et al for the Cystic Fibrosis Inhaled Tobramycin Study Group (member). (1999). Chronic intermittment administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med, 340.

BioMedNet Interview 1 Oct 1999
Moss RB. (1999). BioMedNet Interview 1 Oct 1999. HMS Beagle (on-line, site closed 30 June 2004).

Maxillary sinusitis as a surrogate model for CF gene therapy clinical trials
Wagner JA, Nepumuceno IB, Shah N, Messner AH, Moran ML, & Gardner P. (1999). Maxillary sinusitis as a surrogate model for CF gene therapy clinical trials. J Gene Med, 109.

Bone acquisition and loss in children and adults with cystic fibrosis: A longitudinal study
Bhudhikanok, G. S., Wang, M. C., Marcus, R., Harkins, A., Moss, R. B., & Bachrach, L. K. (1998). Bone acquisition and loss in children and adults with cystic fibrosis: A longitudinal study. JOURNAL OF PEDIATRICS, 133(1), 18-27.

Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus
Wagner, J. A., Reynolds, T., Moran, M. L., Moss, R. B., Wine, J. J., & Gardner, P. (1998). Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus. LANCET, 351(9117), 1702-1703.

A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis
Wagner, J. A., Moran, M. L., Messner, A. H., DAIFUKU, R., Conrad, C. K., & Gardner, P. (1998). A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis. HUMAN GENE THERAPY, 9(6), 889-909.

A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis
Mickle, J. E., Macek, M., Fulmer-Smentek, S. B., Egan, M. M., Schwiebert, E., & Cutting, G. R. (1998). A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. HUMAN MOLECULAR GENETICS, 7(4), 729-735.

Activation of eosinophils in the airways of lung transplantation patients
Dosanjh, A. K., Elashoff, D., Kawalek, A., Moss, R. B., & Esrig, S. (1997). Activation of eosinophils in the airways of lung transplantation patients. CHEST, 112(5), 1180-1183.

A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems
Eisenberg, J., Pepe, M., WILLIAMSWARREN, J., Vasiliev, M., Montgomery, A. B., & PITLICK, W. (1997). A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. CHEST, 111(4), 955-962.

Reduced IL-10 secretion by T cells expressing mutant CFTR: A role for Ca2+ and Cl- channels.
Moss, R. B., Hsu, Y., & Olds, L. (1997). Reduced IL-10 secretion by T cells expressing mutant CFTR: A role for Ca2+ and Cl- channels. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 99(1), 1347-1347.

A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems
Eisenberg J, & Aerosolized Tobramycin Study Group (member). (1997). A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Chest, 1112.

Reduced IL-10 secretion by CD4(+) T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR)
Moss, R. B., BOCIAN, R. C., Hsu, Y. P., Dong, Y. J., Kemna, M., & Gardner, P. (1996). Reduced IL-10 secretion by CD4(+) T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR). CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 106(2), 374-388.

Clinical protocol: AAV-CFTR for the treatment of chronic sinusitis in CF patients.
Wagner, J. A., Moran, M. L., Kouyama, K., Moss, R. B., Wine, J. J., & Gardner, P. (1996). Clinical protocol: AAV-CFTR for the treatment of chronic sinusitis in CF patients. CLINICAL PHARMACOLOGY & THERAPEUTICS, 59(2), PII63-PII63.

When to use a HEPA filter for atopic childhood asthma
Moss RB. (1996). When to use a HEPA filter for atopic childhood asthma. J Respir Dis, 17.

Correlates of osteopenia in patients with cystic fibrosis
Bhudhikanok, G. S., Lim, J., Marcus, R., Harkins, A., Moss, R. B., & Bachrach, L. K. (1996). Correlates of osteopenia in patients with cystic fibrosis. PEDIATRICS, 97(1), 103-111.

Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations
Wilmott RW, Amin RS, Colin A, Devault A, Dozor AJ, & Fuchs HJ. (1996). Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations. Am J Respir Crit Care Med, 153.

Immune therapies for lung infection in cystic fibrosis
Moss RB. (1996). Immune therapies for lung infection in cystic fibrosis. IACFA Newsletter, 46.

CYSTIC-FIBROSIS - PATHOGENESIS, PULMONARY INFECTION, AND TREATMENT
Moss, R. B. (1995). CYSTIC-FIBROSIS - PATHOGENESIS, PULMONARY INFECTION, AND TREATMENT. CLINICAL INFECTIOUS DISEASES, 21(4), 839-849.

ACTIVATION OF CFTR CHLORIDE CURRENT BY NITRIC-OXIDE IN HUMAN T-LYMPHOCYTES
Dong, Y. J., Chao, A. C., Kouyama, K., Hsu, Y. P., BOCIAN, R. C., & Gardner, P. (1995). ACTIVATION OF CFTR CHLORIDE CURRENT BY NITRIC-OXIDE IN HUMAN T-LYMPHOCYTES. EMBO JOURNAL, 14(12), 2700-2707.

MANAGEMENT OF SINUSITIS IN CYSTIC-FIBROSIS BY ENDOSCOPIC SURGERY AND SERIAL ANTIMICROBIAL LAVAGE - REDUCTION IN RECURRENCE REQUIRING SURGERY
Moss, R. B., & KING, V. V. (1995). MANAGEMENT OF SINUSITIS IN CYSTIC-FIBROSIS BY ENDOSCOPIC SURGERY AND SERIAL ANTIMICROBIAL LAVAGE - REDUCTION IN RECURRENCE REQUIRING SURGERY. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 121(5), 566-572.

NEW DRUGS FOR CYSTIC-FIBROSIS LUNG-DISEASE
Moss, R. B. (1995). NEW DRUGS FOR CYSTIC-FIBROSIS LUNG-DISEASE. WESTERN JOURNAL OF MEDICINE, 162(4), 354-355.

ALTERNATIVE PHARMACOTHERAPIES FOR STEROID-DEPENDENT ASTHMA
Moss, R. B. (1995). ALTERNATIVE PHARMACOTHERAPIES FOR STEROID-DEPENDENT ASTHMA. CHEST, 107(3), 817-825.

Inflammatory response in cystic fibrosis lung disease
Moss RB. (1995). Inflammatory response in cystic fibrosis lung disease. New Insights into Cystic Fibrosis, 324.

Sinus disease in cystic fibrosis
Light M, Moss RB, & Davidson TM. (1995). Sinus disease in cystic fibrosis. Gershwin EM and Incaudo GA, Eds. Diseases of the Sinuses: A Comprehensive Textbook of Diagnosis and Treatment. Humana Press, Inc., Totowa NJ.

Practice parameters for the diagnosis and treatment of asthma
Spector SL, Nicklas RA, & Joint Task Force on Practice Parameters (member). (1995). Practice parameters for the diagnosis and treatment of asthma. J Allergy Clin Immunol, 96.

Aerosolized recombinant human DNase reduces respiratory exacerbations and improves pulmonary function in patients with cystic fibrosis
Fuchs HJ, Borowitz DS, Christiansen DH, & et al for the Pulmozyme Study Group (member). (1994). Aerosolized recombinant human DNase reduces respiratory exacerbations and improves pulmonary function in patients with cystic fibrosis. N Engl J Med, 331.

Differential diagnosis of asthma in children
Moss RB. (1994). Differential diagnosis of asthma in children. Gershwin ME and Halpern GM, Eds. Bronchial Asthma. Principles of Diagnosis and Treatment, 3rd Ed, The Humana Press Inc., Totowa NJ.

OSTEOPENIA IN ADULTS WITH CYSTIC-FIBROSIS
Bachrach, L. K., LOUTIT, C. W., Moss, R. B., & Marcus, R. (1994). OSTEOPENIA IN ADULTS WITH CYSTIC-FIBROSIS. AMERICAN JOURNAL OF MEDICINE, 96(1), 27-34.

Outcome measures for clinical trials in cystic fibrosis
Ramsey BW, Boat T, Accurso F, Bennett W, Boucher R, & Wood. (1994). Outcome measures for clinical trials in cystic fibrosis. J Pediatr, 124.

CHRONIC PSEUDOMONAS-AERUGINOSA ENDOBRONCHITIS IN RHESUS-MONKEYS .2. A HISTOPATHOLOGIC ANALYSIS
Cheung, A. Tw., Moss, R. B., Kurland, G., Leong, A. B., & NOVICK, W. J. (1993). CHRONIC PSEUDOMONAS-AERUGINOSA ENDOBRONCHITIS IN RHESUS-MONKEYS .2. A HISTOPATHOLOGIC ANALYSIS. JOURNAL OF MEDICAL PRIMATOLOGY, 22(4), 257-262.

CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR EXPRESSION IN T-CELL CLONES FROM CYSTIC-FIBROSIS PATIENTS
BOCIAN, R. C., Hsu, Y. P., Kemna, M., Dong, Y., Gardner, P., & Moss, R. B. (1993). CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR EXPRESSION IN T-CELL CLONES FROM CYSTIC-FIBROSIS PATIENTS. AMERICAN REVIEW OF RESPIRATORY DISEASE, 147(4), A26-A26.

PASSIVE IMMUNOTHERAPY FOR THE TREATMENT OF ENDOBRONCHITIS IN CYSTIC-FIBROSIS
Moss, R. B. (1993). PASSIVE IMMUNOTHERAPY FOR THE TREATMENT OF ENDOBRONCHITIS IN CYSTIC-FIBROSIS. INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 20, 42-47.

CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR EXPRESSION IN T-CELL CLONES FROM CYSTIC-FIBROSIS PATIENTS
BOCIAN, R. C., Hsu, Y. P., Kemna, M., Dong, Y., Gardner, P., & Moss, R. B. (1993). CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR EXPRESSION IN T-CELL CLONES FROM CYSTIC-FIBROSIS PATIENTS. AMERICAN REVIEW OF RESPIRATORY DISEASE, 147(4), A718-A718.

Immunopathogenesis of cystic fibrosis lung disease
Moss RB. (1993). Immunopathogenesis of cystic fibrosis lung disease. Hillman B (ed). Pediatric Respiratory Diseases: Diagnosis and Treatment. W.B. Saunders, Philadelphia.

Pulmonary defenses
Moss RB. (1993). Pulmonary defenses. Hillman B (ed). Pediatric Respiratory Diseases: Diagnosis and Treatment. W.B. Saunders, Philadelphia, Hillman B (ed). Pediatric Respiratory Diseases: Diagnosis and Treatment. W.B. Saunders, Philadelphia.

Sinusitis and polyposis in cystic fibrosis
Moss RB. (1993). Sinusitis and polyposis in cystic fibrosis. Druce HM, Ed. Sinusitis--Pathophysiology and Treatment. Marcel Dekker, New York.

SELECTIVE POLYSACCHARIDE ANTIBODY DEFICIENCY IN FAMILIAL DIGEORGE SYNDROME
Schubert, M. S., & Moss, R. B. (1992). SELECTIVE POLYSACCHARIDE ANTIBODY DEFICIENCY IN FAMILIAL DIGEORGE SYNDROME. ANNALS OF ALLERGY, 69(3), 231-238.

CHRONIC PSEUDOMONAS-AERUGINOSA ENDOBRONCHITIS IN RHESUS-MONKEYS .1. EFFECT OF PENTOXIFYLLINE ON NEUTROPHIL INFLUX
Cheung, A. Tw., Moss, R. B., Leong, A. B., & NOVICK, W. J. (1992). CHRONIC PSEUDOMONAS-AERUGINOSA ENDOBRONCHITIS IN RHESUS-MONKEYS .1. EFFECT OF PENTOXIFYLLINE ON NEUTROPHIL INFLUX. JOURNAL OF MEDICAL PRIMATOLOGY, 21(7-8), 357-362.

IGG4 DEFICIENCY AND RECURRENT RESPIRATORY-INFECTIONS - REPLY
Moss, R., CARMACK, M. A., & Esrig, S. (1992). IGG4 DEFICIENCY AND RECURRENT RESPIRATORY-INFECTIONS - REPLY. JOURNAL OF PEDIATRICS, 121(2), 332-332.

DEFICIENCY OF IGG4 IN CHILDREN - ASSOCIATION OF ISOLATED IGG4 DEFICIENCY WITH RECURRENT RESPIRATORY-TRACT INFECTION
Moss, R. B., CARMACK, M. A., & Esrig, S. (1992). DEFICIENCY OF IGG4 IN CHILDREN - ASSOCIATION OF ISOLATED IGG4 DEFICIENCY WITH RECURRENT RESPIRATORY-TRACT INFECTION. JOURNAL OF PEDIATRICS, 120(1), 16-21.

Gastroesophageal reflux-associated lung disease
Moss RB. (1992). Gastroesophageal reflux-associated lung disease. Prober CG, Behrman RE (eds). Nelson Self-Assessment in Pediatrics, CME Supplement Test No. ZN9212.

The role of sinus surgery in chronic sinusitis in children
King VV, & Moss RB. (1992). The role of sinus surgery in chronic sinusitis in children. Am J Allergy Asthma Pediatr, 5.

IGE ANTIBODIES IN TICK BITE-INDUCED ANAPHYLAXIS
VANWYE, J. E., Hsu, Y. P., Lane, R. S., Terr, A. I., & Moss, R. B. (1991). IGE ANTIBODIES IN TICK BITE-INDUCED ANAPHYLAXIS. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 88(6), 968-970.

EVALUATION OF THE IMMUNOLOGICAL CROSS-REACTIVITY OF AZTREONAM IN PATIENTS WITH CYSTIC-FIBROSIS WHO ARE ALLERGIC TO PENICILLIN AND OR CEPHALOSPORIN ANTIBIOTICS
Moss, R. B., McClelland, E., Williams, R. R., Hilman, B. C., Rubio, T., & Adkinson, N. F. (1991). EVALUATION OF THE IMMUNOLOGICAL CROSS-REACTIVITY OF AZTREONAM IN PATIENTS WITH CYSTIC-FIBROSIS WHO ARE ALLERGIC TO PENICILLIN AND OR CEPHALOSPORIN ANTIBIOTICS. REVIEWS OF INFECTIOUS DISEASES, 13, S598-S607.

IMMUNOGLOBULIN-G SUBCLASSES
Moss, R. B. (1991). IMMUNOGLOBULIN-G SUBCLASSES. WESTERN JOURNAL OF MEDICINE, 154(4), 458-458.

DRUG ALLERGY IN CYSTIC-FIBROSIS
Moss, R. B. (1991). DRUG ALLERGY IN CYSTIC-FIBROSIS. CLINICAL REVIEWS IN ALLERGY, 9(1-2), 211-229.

ANAPHYLAXIS FROM A TICK BITE
VANWYE, J. E., Hsu, Y. P., Terr, A. I., Moss, R. B., & Lane, R. S. (1991). ANAPHYLAXIS FROM A TICK BITE. NEW ENGLAND JOURNAL OF MEDICINE, 324(11), 777-778.

Anaphylaxis from a tick bite
Van Wye JE, Hsu YP, Lane RS, Terr AI, & Moss RB. (1991). Anaphylaxis from a tick bite. N Engl J Med, 324.

SENSITIZATION TO AZTREONAM AND CROSS-REACTIVITY WITH OTHER BETA-LACTAM ANTIBIOTICS IN HIGH-RISK PATIENTS WITH CYSTIC-FIBROSIS
Moss, R. B. (1991). SENSITIZATION TO AZTREONAM AND CROSS-REACTIVITY WITH OTHER BETA-LACTAM ANTIBIOTICS IN HIGH-RISK PATIENTS WITH CYSTIC-FIBROSIS. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 87(1), 78-88.

LATE PULMONARY SEQUELAE OF BRONCHOPULMONARY DYSPLASIA
Northway, W. H., Moss, R. B., Carlisle, K. B., Parker, B. R., Popp, R. L., & Brown, B. W. (1990). LATE PULMONARY SEQUELAE OF BRONCHOPULMONARY DYSPLASIA. NEW ENGLAND JOURNAL OF MEDICINE, 323(26), 1793-1799.

SINUS DISEASE IN PATIENTS WITH SEVERE CYSTIC-FIBROSIS - RELATION TO PULMONARY EXACERBATION
Umetsu, D. T., Moss, R. B., KING, V. V., & LEWISTON, N. J. (1990). SINUS DISEASE IN PATIENTS WITH SEVERE CYSTIC-FIBROSIS - RELATION TO PULMONARY EXACERBATION. LANCET, 335(8697), 1077-1078.

PSEUDOMONAS HYPERIMMUNE GLOBULIN PASSIVE IMMUNOTHERAPY FOR PULMONARY EXACERBATIONS IN CYSTIC-FIBROSIS
VANWYE, J. E., Collins, M. S., Baylor, M., Pennington, J. E., Hsu, Y. P., & Moss, R. B. (1990). PSEUDOMONAS HYPERIMMUNE GLOBULIN PASSIVE IMMUNOTHERAPY FOR PULMONARY EXACERBATIONS IN CYSTIC-FIBROSIS. PEDIATRIC PULMONOLOGY, 9(1), 7-18.

Cystic Fibrosis. Infection, Immunopathology, and Host Response. Humana Press, Clifton NJ
Moss RB. (1990). Cystic Fibrosis. Infection, Immunopathology, and Host Response. Humana Press, Clifton NJ.

Drug allergy in cystic fibrosis
Moss RB. (1990). Drug allergy in cystic fibrosis. Moss RB (ed). Cystic Fibrosis. Infection, Immunopathology, and Host Response. Humana Press, Clifton NJ.

Antibody production in cystic fibrosis and possibilities for immunotherapy
Moss RB. (1990). Antibody production in cystic fibrosis and possibilities for immunotherapy. Pediatr Pulmonol, Suppl 5.

ALLERGIC ETIOLOGY AND IMMUNOLOGY OF ASTHMA
Moss, R. B. (1989). ALLERGIC ETIOLOGY AND IMMUNOLOGY OF ASTHMA. ANNALS OF ALLERGY, 63(6), 566-577.

NONOPSONIC ANTIBODIES IN CYSTIC-FIBROSIS - PSEUDOMONAS-AERUGINOSA LIPOPOLYSACCHARIDE-SPECIFIC IMMUNOGLOBULIN-G ANTIBODIES FROM INFECTED PATIENT SERA INHIBIT NEUTROPHIL OXIDATIVE RESPONSES
Eichler, I., JORIS, L., Hsu, Y. P., VanWye, J., Bram, R., & Moss, R. (1989). NONOPSONIC ANTIBODIES IN CYSTIC-FIBROSIS - PSEUDOMONAS-AERUGINOSA LIPOPOLYSACCHARIDE-SPECIFIC IMMUNOGLOBULIN-G ANTIBODIES FROM INFECTED PATIENT SERA INHIBIT NEUTROPHIL OXIDATIVE RESPONSES. JOURNAL OF CLINICAL INVESTIGATION, 84(6), 1794-1804.

Regarding article by Earl and Sullivan.
Moss, R. B. (1989). Regarding article by Earl and Sullivan. journal of allergy and clinical immunology, 83(6), 1138-?.

P-AERUGINOSA ENDOBRONCHIAL INFECTION IN CYSTIC-FIBROSIS INDUCES NONOPSONIC IGG2 AND IGG4 LIPOPOLY-SACCHARIDE-SPECIFIC ANTIBODIES
Moss, R., JORIS, L., Eichler, I., VanWye, J., & Hsu, Y. P. (1989). P-AERUGINOSA ENDOBRONCHIAL INFECTION IN CYSTIC-FIBROSIS INDUCES NONOPSONIC IGG2 AND IGG4 LIPOPOLY-SACCHARIDE-SPECIFIC ANTIBODIES. PEDIATRIC RESEARCH, 25(4), A185-A185.

23-YEAR FOLLOW-UP OF BRONCHOPULMONARY DYSPLASIA (BPD)
Northway, W. H., Moss, R. B., Carlisle, K. B., Popp, R. L., Pitlick, P. T., & Brown, B. W. (1989). 23-YEAR FOLLOW-UP OF BRONCHOPULMONARY DYSPLASIA (BPD). PEDIATRIC RESEARCH, 25(4), A370-A370.

Bird fancier's disease in children
Palmer J, Parker BR, Moss R, & Lewiston NJ. (1989). Bird fancier's disease in children. Am J Asthma Allergy Pediatr, 3.

SUPPRESSION OF THE LATE CUTANEOUS RESPONSE BY IMMUNOTHERAPY
Fling, J. A., Ruff, M. E., PARKER, W. A., Whisman, B. A., Martin, M. E., & Reid, M. J. (1989). SUPPRESSION OF THE LATE CUTANEOUS RESPONSE BY IMMUNOTHERAPY. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 83(1), 101-109.

LATE SEQUELAE OF BRONCHOPULMONARY DYSPLASIA (BPD)
Northway, W. H., Parker, B. R., Carlisle, K., Eichler, I., Popp, R. L., & Moss, R. B. (1988). LATE SEQUELAE OF BRONCHOPULMONARY DYSPLASIA (BPD). AMERICAN JOURNAL OF ROENTGENOLOGY, 151(3), 623-623.

LATE SEQUELAE OF BRONCHOPULMONARY DYSPLASIA (BPD)
Northway, W. H., Parker, B. R., Carlisle, K., Eichler, I., Popp, R. L., & Moss, R. B. (1988). LATE SEQUELAE OF BRONCHOPULMONARY DYSPLASIA (BPD). PEDIATRIC RADIOLOGY, 18(5), 442-442.

MOUNTAIN CEDAR POLLINOSIS - CAN IT OCCUR IN NON-ATOPICS
Reid, M. J., Schwietz, L. A., Whisman, B. A., & Moss, R. B. (1988). MOUNTAIN CEDAR POLLINOSIS - CAN IT OCCUR IN NON-ATOPICS. NEW ENGLAND AND REGIONAL ALLERGY PROCEEDINGS, 9(3), 225-232.

SPUTUM CHANGES ASSOCIATED WITH THERAPY FOR ENDOBRONCHIAL EXACERBATION IN CYSTIC-FIBROSIS
Smith, A. L., Redding, G., Doershuk, C., Goldmann, D., Gore, E., & YOGEV, R. (1988). SPUTUM CHANGES ASSOCIATED WITH THERAPY FOR ENDOBRONCHIAL EXACERBATION IN CYSTIC-FIBROSIS. JOURNAL OF PEDIATRICS, 112(4), 547-554.

Assessment of validity of allergen reactivity with multiple skin prick testing, RAST, EAST, and rocket immunoelectrophoresi
Eichler I, Gotz M, Jarisch R, & Moss R. (1988). Assessment of validity of allergen reactivity with multiple skin prick testing, RAST, EAST, and rocket immunoelectrophoresi. Allergy, 43.

THE ROLE OF IGG SUBCLASS ANTIBODIES IN CHRONIC INFECTION - THE CASE OF CYSTIC-FIBROSIS
Moss, R. B. (1988). THE ROLE OF IGG SUBCLASS ANTIBODIES IN CHRONIC INFECTION - THE CASE OF CYSTIC-FIBROSIS. NEW ENGLAND AND REGIONAL ALLERGY PROCEEDINGS, 9(1), 57-61.

Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis
Smith AL, Redding G, Doershuk C, Goldman D, Gore E, & Yogev R. (1988). Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr, 1112.

Allergy evaluation in children: skin testing and RAST
Moss RB. (1988). Allergy evaluation in children: skin testing and RAST. Am J Asthma Allergy Pediatr, 110.

EFFECT OF TOTAL LYMPHOID IRRADIATION ON IGE ANTIBODY-RESPONSES IN RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
Terr, A. I., Moss, R. B., & Strober, S. (1987). EFFECT OF TOTAL LYMPHOID IRRADIATION ON IGE ANTIBODY-RESPONSES IN RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 80(6), 798-802.

ALTERED ANTIBODY ISOTYPE IN CYSTIC-FIBROSIS - IMPAIRED NATURAL ANTIBODY-RESPONSE TO POLYSACCHARIDE ANTIGENS
Moss, R. B., Hsu, Y. P., VANEEDE, P. H., VANLEEUWEN, A. M., LEWISTON, N. J., & DeLange, G. (1987). ALTERED ANTIBODY ISOTYPE IN CYSTIC-FIBROSIS - IMPAIRED NATURAL ANTIBODY-RESPONSE TO POLYSACCHARIDE ANTIGENS. PEDIATRIC RESEARCH, 22(6), 708-713.

IGG SUBCLASS ANTIBODY MARKERS IN GRASS-POLLEN IMMUNOTHERAPY
Moss, R. B. (1987). IGG SUBCLASS ANTIBODY MARKERS IN GRASS-POLLEN IMMUNOTHERAPY. NEW ENGLAND AND REGIONAL ALLERGY PROCEEDINGS, 8(6), 409-415.

PERFORMANCE-CHARACTERISTICS OF IMMUNOENZYMATIC ALLERGOSORBENT TESTING FOR TOTAL AND SPECIFIC IMMUNOGLOBULIN-E
Moss, R., Hsu, Y. P., & Esrig, S. (1987). PERFORMANCE-CHARACTERISTICS OF IMMUNOENZYMATIC ALLERGOSORBENT TESTING FOR TOTAL AND SPECIFIC IMMUNOGLOBULIN-E. ANNALS OF ALLERGY, 59(3), 185-191.

INTEROBSERVER VARIANCE IN CLINICAL SCORING FOR CYSTIC-FIBROSIS
LEWISTON, N., Moss, R., Hindi, R., Rubinstein, S., & Sullivan, M. (1987). INTEROBSERVER VARIANCE IN CLINICAL SCORING FOR CYSTIC-FIBROSIS. CHEST, 91(6), 878-882.

IMMUNOGLOBULIN-E ANTIBODIES IN YOUNG-CHILDREN WITH POSSIBLE ALLERGIC SYMPTOMS
LEWISTON, N., Hindi, R., Hsu, Y. P., LEWISTON, J., & Moss, R. (1987). IMMUNOGLOBULIN-E ANTIBODIES IN YOUNG-CHILDREN WITH POSSIBLE ALLERGIC SYMPTOMS. JOURNAL OF PEDIATRICS, 110(5), 738-740.

IMPAIRED NATURAL IGG2 ANTIBODY (AB) RESPONSE TO POLYSACCHARIDE ANTIGENS AND DECREASED KM(1)-A2M(2) ALLOTYPES IN CYSTIC-FIBROSIS (CF)
Moss, R. B., Hsu, Y. P., LEWISTON, N. J., & DeLange, G. (1987). IMPAIRED NATURAL IGG2 ANTIBODY (AB) RESPONSE TO POLYSACCHARIDE ANTIGENS AND DECREASED KM(1)-A2M(2) ALLOTYPES IN CYSTIC-FIBROSIS (CF). PEDIATRIC RESEARCH, 21(4), A330-A330.

HYPERGAMMAGLOBULINEMIA IN CYSTIC-FIBROSIS
Moss, R. B. (1987). HYPERGAMMAGLOBULINEMIA IN CYSTIC-FIBROSIS. CHEST, 91(4), 522-526.

ISOTYPIC AND ANTIGENIC RESTRICTION OF THE BLOCKING ANTIBODY-RESPONSE TO RYEGRASS POLLEN - CORRELATION OF RYE GROUP-I ANTIGEN-SPECIFIC IGG1 WITH CLINICAL-RESPONSE
Moss, R. B., Hsu, Y. P., KWASNICKI, J. M., Reid, M. J., & Sullivan, M. M. (1987). ISOTYPIC AND ANTIGENIC RESTRICTION OF THE BLOCKING ANTIBODY-RESPONSE TO RYEGRASS POLLEN - CORRELATION OF RYE GROUP-I ANTIGEN-SPECIFIC IGG1 WITH CLINICAL-RESPONSE. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 79(2), 387-398.

IgE antibodies in young children with possible allergic symptoms
Lewiston NJ, Hindi R, Hsu YP, Lewiston J, & Moss RB. (1987). IgE antibodies in young children with possible allergic symptoms. J Pediatr, 110.

Performance characteristics of immunoenzymatic testing for total and specific immunoglobulin E. Comparison of conventional assay with a microtiter plate accelerated computerized procedure
Moss RB, Hsu Y, & Esrig S. (1987). Performance characteristics of immunoenzymatic testing for total and specific immunoglobulin E. Comparison of conventional assay with a microtiter plate accelerated computerized procedure. Ann Allergy, 59.

Antibody and immune complex production in cystic fibrosis
Moss RB. (1987). Antibody and immune complex production in cystic fibrosis. Pediatr Pulmonol, Suppl 1.

IgG subclass antibody markers in grass pollen immunotherapy
Moss RB. (1987). IgG subclass antibody markers in grass pollen immunotherapy. Allergy Proceed.

Interobserver variance in clinical scoring for cystic fibrosis
Lewiston NJ, Moss RB, Hindi R, Rubinstein S, & Sullivan MM. (1987). Interobserver variance in clinical scoring for cystic fibrosis. Chest, 91.

SEASONAL ASTHMA IN NORTHERN CALIFORNIA - ALLERGIC CAUSES AND EFFICACY OF IMMUNOTHERAPY
Reid, M. J., Moss, R. B., Hsu, Y. P., KWASNICKI, J. M., COMMERFORD, T. M., & Nelson, B. L. (1986). SEASONAL ASTHMA IN NORTHERN CALIFORNIA - ALLERGIC CAUSES AND EFFICACY OF IMMUNOTHERAPY. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 78(4), 590-600.

CONSTIPATION AND MECONIUM ILEUS EQUIVALENT IN PATIENTS WITH CYSTIC-FIBROSIS
Rubinstein, S., Moss, R., & LEWISTON, N. (1986). CONSTIPATION AND MECONIUM ILEUS EQUIVALENT IN PATIENTS WITH CYSTIC-FIBROSIS. PEDIATRICS, 78(3), 473-479.

SUPRAVENTRICULAR TACHYCARDIA IN PATIENTS WITH CYSTIC-FIBROSIS
Sullivan, M. M., Moss, R. B., HINDI, R. D., & LEWISTON, N. J. (1986). SUPRAVENTRICULAR TACHYCARDIA IN PATIENTS WITH CYSTIC-FIBROSIS. CHEST, 90(2), 239-242.

ALTERED ANTIBODY ISOTYPE IN CYSTIC-FIBROSIS - POSSIBLE ROLE IN OPSONIC DEFICIENCY
Moss, R. B., Hsu, Y. P., Sullivan, M. M., & LEWISTON, N. J. (1986). ALTERED ANTIBODY ISOTYPE IN CYSTIC-FIBROSIS - POSSIBLE ROLE IN OPSONIC DEFICIENCY. PEDIATRIC RESEARCH, 20(5), 453-459.

ASSOCIATION OF SYSTEMIC IMMUNE-COMPLEXES, COMPLEMENT ACTIVATION, AND ANTIBODIES TO PSEUDOMONAS-AERUGINOSA LIPOPOLYSACCHARIDE AND EXOTOXIN-A WITH MORTALITY IN CYSTIC-FIBROSIS
Moss, R. B., Hsu, Y. P., LEWISTON, N. J., Curd, J. G., Milgrom, H., & Larrick, J. W. (1986). ASSOCIATION OF SYSTEMIC IMMUNE-COMPLEXES, COMPLEMENT ACTIVATION, AND ANTIBODIES TO PSEUDOMONAS-AERUGINOSA LIPOPOLYSACCHARIDE AND EXOTOXIN-A WITH MORTALITY IN CYSTIC-FIBROSIS. AMERICAN REVIEW OF RESPIRATORY DISEASE, 133(4), 648-652.

IGG SUBCLASSES IN RESPIRATORY DISORDERS - CYSTIC-FIBROSIS
Moss, R. B. (1986). IGG SUBCLASSES IN RESPIRATORY DISORDERS - CYSTIC-FIBROSIS. MONOGRAPHS IN ALLERGY, 19, 202-209.

IgG subclasses in respiratory disorders: cystic fibrosis
Moss RB. (1986). IgG subclasses in respiratory disorders: cystic fibrosis. Shakib F (ed), Basic and Clinical Aspects of IgG Subclasses. Monographs in Allergy, vol. 19. SW Karger, Basel.

Constipation and meconium ileus equivalent in cystic fibrosis
Rubinstein S, Moss RB, & Lewiston NJ. (1986). Constipation and meconium ileus equivalent in cystic fibrosis. Pediatrics, 78.

Cow's milk allergy in breast fed infants. Role of allergen and breast milk secretory IgA antibody
Machtinger S, & Moss RB. (1986). Cow's milk allergy in breast fed infants. Role of allergen and breast milk secretory IgA antibody. J Allergy Clin Immunol, 77.

Generation and characterization of human monoclonal anti-Pseudomonas aeruginosa antibodies
Larrick JW, Hart SM, Lippman D, Glembourtt M, Hsu YP, & Moss RB. (1986). Generation and characterization of human monoclonal anti-Pseudomonas aeruginosa antibodies. Strelkauskas A (ed), Human Hybridomas: Diagnostic and Therapeutic Applications. Marcel Dekker, Inc., New York.

Immune complexes in CF: keys to new clinical insight
Lewiston NJ, & Moss RB. (1986). Immune complexes in CF: keys to new clinical insight. J Respir Dis, 7.

In vitro expansion of human B cells for the production of human monoclonal antibodies
Larrick JW, Dyer BJ, Senyk G, Hart SM, Moss RB, & Raubitschek AA. (1985). In vitro expansion of human B cells for the production of human monoclonal antibodies. Engleman EG, Foung SKH, Larrick JW, Raubitschek AA (eds), Human Hybridomas and Monoclonal Antibodies. Plenum Press, NY.

CYSTIC-FIBROSIS AND NEURO-BLASTOMA
Moss, R. B., BLESSINGMOORE, J., Bender, S. W., & Weibel, A. (1985). CYSTIC-FIBROSIS AND NEURO-BLASTOMA. PEDIATRICS, 76(5), 814-817.

UNDERESTIMATION OF SPECIFIC IMMUNOGLOBULIN-E BY MICROTITER PLATE ENZYME-LINKED IMMUNOSORBENT ASSAYS
Reid, M. J., KWASNICKI, J. M., Moss, R. B., & Cheung, N. Kv. (1985). UNDERESTIMATION OF SPECIFIC IMMUNOGLOBULIN-E BY MICROTITER PLATE ENZYME-LINKED IMMUNOSORBENT ASSAYS. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 76(2), 172-176.

Allergic phenomena in cystic fibrosis
Lewiston NJ, & Moss RB. (1984). Allergic phenomena in cystic fibrosis. Shapira E, Wilson GB (eds), Immunological Aspects of Cystic Fibrosis. CRC Press Inc., Boca Raton.

ALLERGY TO SEMISYNTHETIC PENICILLINS IN CYSTIC-FIBROSIS
Moss, R. B., Babin, S., Hsu, Y. P., BLESSINGMOORE, J., & LEWISTON, N. J. (1984). ALLERGY TO SEMISYNTHETIC PENICILLINS IN CYSTIC-FIBROSIS. JOURNAL OF PEDIATRICS, 104(3), 460-466.

GRASS-POLLEN IMMUNOTHERAPY - A SINGLE YEAR DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN PATIENTS WITH GRASS POLLEN-INDUCED ASTHMA AND RHINITIS
Ortolani, C., Pastorello, E., Moss, R. B., Hsu, Y. P., Restuccia, M., & Zanussi, C. (1984). GRASS-POLLEN IMMUNOTHERAPY - A SINGLE YEAR DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN PATIENTS WITH GRASS POLLEN-INDUCED ASTHMA AND RHINITIS. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 73(2), 283-290.

Immunopathology of cystic fibrosis
Moss RB. (1984). Immunopathology of cystic fibrosis. Shapira E, Wilson GB (eds), Immunological Aspects of Cystic Fibrosis. CRC Press Inc., Boca Raton.

SUDDEN-DEATH IN ADOLESCENT ASTHMA
Rubinstein, S., HINDI, R. D., Moss, R. B., BLESSINGMOORE, J., & LEWISTON, N. J. (1984). SUDDEN-DEATH IN ADOLESCENT ASTHMA. ANNALS OF ALLERGY, 53(4), 311-318.

IGE AND IGG ANTIBODIES TO CASEIN IN SUSPECTED COWS MILK ALLERGY
LEONG, R. E., Moss, R. B., BLESSINGMOORE, J., Cheung, N. K., Chau, I., & LEWISTON, N. J. (1983). IGE AND IGG ANTIBODIES TO CASEIN IN SUSPECTED COWS MILK ALLERGY. ANNALS OF ALLERGY, 50(5), 352-352.

A microtiter immunoenzymatic assay for antigen-specific IgG4 subclass antibodies
Hsu YP, & Moss RB. (1983). A microtiter immunoenzymatic assay for antigen-specific IgG4 subclass antibodies. Clin Rev Allergy.

Enzyme immunoassay for honeybee venom specific IgG4
Halpern GM, Moss RB, Hsu YP, & Blessing J. (1983). Enzyme immunoassay for honeybee venom specific IgG4. Avrameas S (ed), Immunoenzymatic Techniques. Elsevier Science Publishers, Amsterdam.

IgG4 antibody to Pseudomonas aeruginosa in cystic fibrosis
Moss RB, Hsu YP, Leahy M, & Halpern G. (1983). IgG4 antibody to Pseudomonas aeruginosa in cystic fibrosis. Kerr JW, Ganderton MA (eds), Proceedings of Invited Symposia, XII International Congress of Allergology and Clinical Immunology, Macmillan, London.

MICROTITER IMMUNOENZYMATIC ASSAY (MICRO-ELISA) FOR ANTIGEN SPECIFIC IGG4 SUBCLASS ANTIBODY
Hsu, Y. P., & Moss, R. B. (1983). MICROTITER IMMUNOENZYMATIC ASSAY (MICRO-ELISA) FOR ANTIGEN SPECIFIC IGG4 SUBCLASS ANTIBODY. CLINICAL REVIEWS IN ALLERGY, 1(2), 231-236.

Immunology of cystic fibrosis: immunity, immunodeficiency, and hypersensitivity.
Moss RB. (1983). Immunology of cystic fibrosis: immunity, immunodeficiency, and hypersensitivity. Lloyd-Still JD (ed), Textbook of Cystic Fibrosis. Wright-PSG Publishing Inc., Boston.

ISOLATION AND CHARACTERIZATION OF CIRCULATING IMMUNE-COMPLEXES IN CYSTIC-FIBROSIS
Moss, R. B., & Hsu, Y. P. (1982). ISOLATION AND CHARACTERIZATION OF CIRCULATING IMMUNE-COMPLEXES IN CYSTIC-FIBROSIS. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 47(2), 301-308.

ASSOCIATION OF CIRCULATING IMMUNE-COMPLEXES WITH CLINICAL AND PULMONARY STATUS IN CYSTIC-FIBROSIS
Moss, R., Hsu, Y. P., Jost, S., REID, M., & LEWISTON, N. (1981). ASSOCIATION OF CIRCULATING IMMUNE-COMPLEXES WITH CLINICAL AND PULMONARY STATUS IN CYSTIC-FIBROSIS. CLINICAL RESEARCH, 29(1), A100-A100.

I-125-CLQ-BINDING AND SPECIFIC ANTIBODIES AS INDICATORS OF PULMONARY-DISEASE ACTIVITY IN CYSTIC-FIBROSIS
Moss, R. B., Hsu, Y. P., & LEWISTON, N. J. (1981). I-125-CLQ-BINDING AND SPECIFIC ANTIBODIES AS INDICATORS OF PULMONARY-DISEASE ACTIVITY IN CYSTIC-FIBROSIS. JOURNAL OF PEDIATRICS, 99(2), 215-222.

IMMUNE-COMPLEXES AND HUMORAL RESPONSE TO PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS
Moss, R. B., & LEWISTON, N. J. (1980). IMMUNE-COMPLEXES AND HUMORAL RESPONSE TO PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS. AMERICAN REVIEW OF RESPIRATORY DISEASE, 121(1), 23-29.

Cuirass ventilation in childhood neuromuscular disease
O'Leary J, Moss RB, King R, Liebhaber M, & Lewiston N. (1979). Cuirass ventilation in childhood neuromuscular disease. J Pediatr, 94.

The immunologic and clinical associations of the split products of C'3 in plasma in juvenile rheumatoid arthritis
Miller JJ, Hsu YP, Moss RB, & Olds L. (1979). The immunologic and clinical associations of the split products of C'3 in plasma in juvenile rheumatoid arthritis. Arth Rheum, 22.

CHRONIC NEUROPATHY PRESENTING AS A FLOPPY INFANT WITH RESPIRATORY-DISTRESS
Moss, R. B., Sriram, S., KELTS, K. A., Forno, L. S., & LEWISTON, N. J. (1979). CHRONIC NEUROPATHY PRESENTING AS A FLOPPY INFANT WITH RESPIRATORY-DISTRESS. PEDIATRICS, 64(4), 459-464.

CUIRASS VENTILATION IN CHILDHOOD NEUROMUSCULAR DISEASE
OLEARY, J., Moss, R., King, R., LeBlanc, M., Liebhaber, M., & LEWISTON, N. (1978). CUIRASS VENTILATION IN CHILDHOOD NEUROMUSCULAR DISEASE. AMERICAN REVIEW OF RESPIRATORY DISEASE, 117(4), 301-301.